Genetic Screens: A Route to Rapid Progress in Disease Targeting and Drug Development

The Scientist brings together a panel of experts to share their perspectives on genome-wide functional screening and applications in drug development.

By The Scientist Marketing Team | February 15, 2016

The Scientist brings together a panel of experts to share their perspectives on genome-wide functional screening and applications in drug development.

Genetic screens are powerful techniques to investigate gene function, dissect complex biological processes, and rapidly assess drug targets. Advances in CRISPR/Cas9 technology have led to remarkable progress in this relatively new field. The Scientist brings together a panel of experts to share their perspectives on genome-wide functional screening and applications in drug development. Attendees can interact with the panel during the live webinar by asking questions and sharing their experiences.

Topics to be covered:

  • Application of genome-scale gain- and loss-of-function screening using the CRISPR system
  • Identification of biomarkers associated with genetic vulnerabilities in genome-scale knockout screens
  • Use of synthetic drug screens to evaluate drug efficacy in different tumor mutational backgrounds

Meet the Speakers:

Dr. Feng Zhang
Core Member
Broad Institute of MIT and Harvard
Keck Career Development Professor
Massachusetts Institute of Technology

 

Dr. Traver Hart
Assistant Professor
Department of Bioinformatics and Computational Biology
MD Anderson Cancer Center

 

Horizon

Add a Comment

Avatar of: You

You

Processing...
Processing...

Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo

Popular Now

  1. Prominent Salk Institute Scientist Inder Verma Resigns
  2. Dartmouth Professor Investigated for Sexual Misconduct Retires
  3. Theranos Leaders Indicted For Fraud
    The Nutshell Theranos Leaders Indicted For Fraud

    Federal prosecutors filed criminal charges that allege the company’s promise to revolutionize blood testing swindled investors out of hundreds of millions of dollars and put patients in danger.

  4. Probiotics Prevent Cholera in Animal Models